Nelson N. Stone, MD, presented “Should MRI Be Used to Monitor for AS? Con Argument” during the 23rd Annual Southwest Prostate Cancer Update on April 15, 2018 in Scottsdale, Arizona
How to cite: Stone, Nelson N. “Should MRI Be Used to Monitor for AS? Con Argument” April 15, 2018. Accessed [date today]. https://dev.grandroundsinurology.com/should-mri-be-used-to-monitor-for-as-con-argument/
Should MRI Be Used to Monitor for AS? Con Argument – Summary:
Nelson N. Stone, MD, argues that MRI’s limitations make it insufficient for evaluating and managing prostate cancer patients under consideration for active surveillance (AS) or targeted focal therapy (TFT). Instead, urologists should consider technology like the under-development 3DBiopsy™ system, with a transperineal needle along with mapping software. This approach can detect the precise location of lesions and create a roadmap for treatment planning.
This presentation is a response to “Should MRI Be Used to Monitor for AS? Pro Argument” by Peter A. Pinto, MD.